Paul Darden
Concepts (284)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaccination | 22 | 2023 | 298 | 4.790 |
Why?
| Papillomavirus Vaccines | 15 | 2023 | 68 | 4.650 |
Why?
| Pediatrics | 23 | 2015 | 323 | 2.920 |
Why?
| Meningococcal Vaccines | 8 | 2020 | 13 | 2.870 |
Why?
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 7 | 2020 | 10 | 2.700 |
Why?
| Immunization | 12 | 2023 | 95 | 2.590 |
Why?
| Parents | 12 | 2023 | 346 | 2.460 |
Why?
| Vaccines | 4 | 2022 | 65 | 1.740 |
Why?
| Patient Acceptance of Health Care | 5 | 2019 | 331 | 1.270 |
Why?
| Immunization Schedule | 8 | 2020 | 22 | 1.260 |
Why?
| Immunization Programs | 5 | 2011 | 28 | 1.230 |
Why?
| Papillomavirus Infections | 6 | 2023 | 163 | 1.180 |
Why?
| Physician-Patient Relations | 5 | 2015 | 134 | 1.160 |
Why?
| Continuity of Patient Care | 7 | 2008 | 63 | 1.130 |
Why?
| South Carolina | 19 | 2018 | 42 | 1.100 |
Why?
| Internship and Residency | 12 | 2008 | 501 | 1.100 |
Why?
| Health Knowledge, Attitudes, Practice | 7 | 2022 | 541 | 1.090 |
Why?
| Child | 35 | 2023 | 7368 | 1.010 |
Why?
| Poverty | 3 | 2015 | 231 | 0.920 |
Why?
| Adolescent | 25 | 2023 | 6900 | 0.910 |
Why?
| Oklahoma | 6 | 2022 | 29 | 0.870 |
Why?
| Rural Population | 4 | 2023 | 598 | 0.840 |
Why?
| Humans | 76 | 2023 | 54391 | 0.830 |
Why?
| Overweight | 2 | 2022 | 240 | 0.810 |
Why?
| United States | 22 | 2022 | 5208 | 0.770 |
Why?
| Reminder Systems | 2 | 2018 | 30 | 0.740 |
Why?
| Diphtheria | 2 | 2015 | 2 | 0.700 |
Why?
| Tetanus | 2 | 2015 | 8 | 0.700 |
Why?
| Whooping Cough | 2 | 2015 | 15 | 0.690 |
Why?
| Influenza Vaccines | 3 | 2018 | 42 | 0.670 |
Why?
| Appointments and Schedules | 2 | 2018 | 28 | 0.670 |
Why?
| Information Services | 2 | 2008 | 14 | 0.670 |
Why?
| Clinical Medicine | 2 | 2008 | 6 | 0.660 |
Why?
| Text Messaging | 1 | 2018 | 18 | 0.640 |
Why?
| Primary Health Care | 7 | 2022 | 398 | 0.640 |
Why?
| Language | 2 | 2016 | 137 | 0.630 |
Why?
| Male | 36 | 2020 | 27347 | 0.620 |
Why?
| Female | 36 | 2022 | 28471 | 0.620 |
Why?
| Infant | 23 | 2011 | 3829 | 0.610 |
Why?
| Child, Preschool | 24 | 2014 | 4158 | 0.610 |
Why?
| Communication Barriers | 2 | 2015 | 38 | 0.590 |
Why?
| Child Abuse | 2 | 2016 | 170 | 0.580 |
Why?
| Meningococcal Infections | 1 | 2015 | 7 | 0.560 |
Why?
| Practice Guidelines as Topic | 4 | 2014 | 489 | 0.550 |
Why?
| Translating | 1 | 2015 | 16 | 0.550 |
Why?
| Sentinel Surveillance | 2 | 2014 | 12 | 0.530 |
Why?
| Periodicals as Topic | 1 | 2016 | 65 | 0.530 |
Why?
| Craniocerebral Trauma | 1 | 2016 | 89 | 0.510 |
Why?
| Health Status Disparities | 2 | 2014 | 219 | 0.500 |
Why?
| Quality Indicators, Health Care | 3 | 2011 | 98 | 0.470 |
Why?
| Uterine Cervical Neoplasms | 1 | 2015 | 276 | 0.440 |
Why?
| Child Welfare | 4 | 2021 | 73 | 0.440 |
Why?
| Indians, North American | 3 | 2021 | 38 | 0.420 |
Why?
| Guideline Adherence | 2 | 2011 | 148 | 0.410 |
Why?
| Obesity | 3 | 2022 | 1203 | 0.400 |
Why?
| Prevalence | 6 | 2016 | 1025 | 0.390 |
Why?
| Health Records, Personal | 1 | 2010 | 10 | 0.370 |
Why?
| Cross-Sectional Studies | 9 | 2022 | 1696 | 0.370 |
Why?
| Health Services Accessibility | 1 | 2014 | 428 | 0.360 |
Why?
| Outpatient Clinics, Hospital | 3 | 2018 | 44 | 0.360 |
Why?
| Patient-Centered Care | 1 | 2011 | 132 | 0.360 |
Why?
| Data Collection | 3 | 2019 | 320 | 0.360 |
Why?
| Health Surveys | 3 | 2015 | 261 | 0.360 |
Why?
| Body Weight | 2 | 2010 | 578 | 0.350 |
Why?
| Infant Equipment | 1 | 2008 | 3 | 0.330 |
Why?
| Health Insurance Portability and Accountability Act | 1 | 2008 | 13 | 0.330 |
Why?
| Hepatitis B Vaccines | 1 | 2008 | 5 | 0.330 |
Why?
| Workload | 1 | 2008 | 52 | 0.320 |
Why?
| Hepatitis B | 1 | 2008 | 27 | 0.320 |
Why?
| Quality Improvement | 3 | 2018 | 245 | 0.310 |
Why?
| Population Surveillance | 1 | 2008 | 183 | 0.300 |
Why?
| Ambulatory Care | 3 | 2007 | 231 | 0.300 |
Why?
| Telemedicine | 2 | 2023 | 453 | 0.290 |
Why?
| Logistic Models | 6 | 2014 | 991 | 0.270 |
Why?
| Focus Groups | 2 | 2023 | 207 | 0.260 |
Why?
| Health Personnel | 2 | 2018 | 247 | 0.260 |
Why?
| Body Mass Index | 2 | 2022 | 712 | 0.250 |
Why?
| Cost Savings | 1 | 2004 | 67 | 0.240 |
Why?
| Patient Care | 1 | 2004 | 65 | 0.240 |
Why?
| Otitis Media | 2 | 1996 | 30 | 0.240 |
Why?
| Complementary Therapies | 1 | 2003 | 31 | 0.220 |
Why?
| Infant, Newborn | 8 | 2008 | 2923 | 0.220 |
Why?
| Private Practice | 2 | 2001 | 12 | 0.220 |
Why?
| Hypercholesterolemia | 3 | 1992 | 42 | 0.220 |
Why?
| Health Care Surveys | 3 | 2013 | 195 | 0.220 |
Why?
| Qualitative Research | 1 | 2023 | 326 | 0.210 |
Why?
| Office Visits | 3 | 2011 | 48 | 0.200 |
Why?
| Socioeconomic Factors | 5 | 2014 | 639 | 0.200 |
Why?
| Capacity Building | 1 | 2021 | 19 | 0.200 |
Why?
| Communication | 2 | 2020 | 265 | 0.200 |
Why?
| House Calls | 2 | 2015 | 28 | 0.190 |
Why?
| Emergency Service, Hospital | 1 | 2004 | 543 | 0.180 |
Why?
| Professional Practice | 2 | 2019 | 21 | 0.170 |
Why?
| Physicians, Family | 1 | 1999 | 47 | 0.170 |
Why?
| Clinical Trials as Topic | 1 | 2021 | 491 | 0.170 |
Why?
| Feedback, Psychological | 1 | 2018 | 20 | 0.160 |
Why?
| Oregon | 3 | 2023 | 15 | 0.160 |
Why?
| Professional-Patient Relations | 1 | 2018 | 52 | 0.160 |
Why?
| Time Factors | 4 | 2011 | 3210 | 0.150 |
Why?
| Multivariate Analysis | 2 | 2012 | 643 | 0.150 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1996 | 2 | 0.150 |
Why?
| Evidence-Based Medicine | 2 | 2008 | 276 | 0.150 |
Why?
| Hospitals, Pediatric | 1 | 1998 | 270 | 0.150 |
Why?
| Spain | 1 | 2016 | 18 | 0.140 |
Why?
| Nasal Decongestants | 1 | 1996 | 3 | 0.140 |
Why?
| Common Cold | 1 | 1996 | 6 | 0.140 |
Why?
| Phenylephrine | 1 | 1996 | 34 | 0.140 |
Why?
| Age Factors | 3 | 2018 | 1199 | 0.140 |
Why?
| Fellowships and Scholarships | 2 | 2007 | 117 | 0.140 |
Why?
| Eustachian Tube | 1 | 1996 | 15 | 0.140 |
Why?
| Mothers | 2 | 2015 | 248 | 0.140 |
Why?
| Adult | 6 | 2018 | 14207 | 0.140 |
Why?
| Multilingualism | 1 | 2015 | 10 | 0.140 |
Why?
| Minnesota | 1 | 2015 | 27 | 0.140 |
Why?
| Counseling | 3 | 1992 | 147 | 0.140 |
Why?
| Terminology as Topic | 1 | 2016 | 72 | 0.140 |
Why?
| Utilization Review | 1 | 2015 | 36 | 0.140 |
Why?
| Linear Models | 2 | 2008 | 308 | 0.130 |
Why?
| Age Distribution | 2 | 2008 | 199 | 0.130 |
Why?
| Sex Factors | 1 | 2018 | 766 | 0.130 |
Why?
| Adolescent Medicine | 1 | 1995 | 7 | 0.130 |
Why?
| Retrospective Studies | 6 | 2011 | 6459 | 0.130 |
Why?
| Education, Medical, Graduate | 2 | 2007 | 226 | 0.130 |
Why?
| Ambulatory Care Facilities | 1 | 2015 | 138 | 0.130 |
Why?
| Health Services Needs and Demand | 1 | 1996 | 190 | 0.120 |
Why?
| Education, Medical, Continuing | 1 | 1995 | 79 | 0.120 |
Why?
| School Health Services | 1 | 2015 | 52 | 0.120 |
Why?
| Cooperative Behavior | 1 | 2016 | 253 | 0.120 |
Why?
| Sex Distribution | 1 | 2014 | 159 | 0.120 |
Why?
| Nutrition Surveys | 1 | 2014 | 122 | 0.120 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2022 | 594 | 0.120 |
Why?
| Attitude of Health Personnel | 4 | 2007 | 390 | 0.120 |
Why?
| Incidence | 2 | 2016 | 1083 | 0.120 |
Why?
| Diphtheria-Tetanus Vaccine | 1 | 2013 | 1 | 0.120 |
Why?
| Attitude | 1 | 2013 | 81 | 0.110 |
Why?
| Databases, Factual | 1 | 2015 | 683 | 0.110 |
Why?
| Clinical Competence | 5 | 1999 | 444 | 0.110 |
Why?
| Perception | 1 | 2013 | 142 | 0.110 |
Why?
| Interviews as Topic | 1 | 2013 | 314 | 0.100 |
Why?
| Food Assistance | 1 | 2012 | 25 | 0.100 |
Why?
| History, 17th Century | 1 | 2011 | 10 | 0.100 |
Why?
| History, 18th Century | 1 | 2011 | 10 | 0.100 |
Why?
| Smallpox | 1 | 2011 | 3 | 0.100 |
Why?
| Typhoid Fever | 1 | 2011 | 18 | 0.100 |
Why?
| History, 19th Century | 1 | 2011 | 34 | 0.100 |
Why?
| Poliomyelitis | 1 | 2011 | 15 | 0.100 |
Why?
| History, 21st Century | 1 | 2011 | 62 | 0.100 |
Why?
| Forms and Records Control | 1 | 2011 | 12 | 0.100 |
Why?
| Cefaclor | 1 | 1990 | 1 | 0.100 |
Why?
| History, 20th Century | 1 | 2011 | 114 | 0.100 |
Why?
| Cefuroxime | 1 | 1990 | 4 | 0.100 |
Why?
| Clavulanic Acids | 1 | 1990 | 9 | 0.100 |
Why?
| Healthcare Disparities | 1 | 2014 | 269 | 0.100 |
Why?
| Hospitals, University | 2 | 2004 | 89 | 0.100 |
Why?
| Amoxicillin | 1 | 1990 | 22 | 0.100 |
Why?
| Influenza, Human | 1 | 2011 | 120 | 0.090 |
Why?
| Teaching | 1 | 1991 | 125 | 0.090 |
Why?
| Drug Therapy, Combination | 1 | 1990 | 426 | 0.090 |
Why?
| Infant Welfare | 1 | 2008 | 8 | 0.080 |
Why?
| Middle Aged | 4 | 2015 | 13082 | 0.080 |
Why?
| Family Practice | 2 | 2019 | 70 | 0.080 |
Why?
| Headache | 1 | 2008 | 78 | 0.080 |
Why?
| Safety | 2 | 2021 | 92 | 0.080 |
Why?
| Biomedical Research | 1 | 2011 | 241 | 0.080 |
Why?
| Curriculum | 3 | 2007 | 434 | 0.080 |
Why?
| Neoplasms | 1 | 2018 | 1322 | 0.080 |
Why?
| Social Class | 1 | 2008 | 109 | 0.080 |
Why?
| Faculty, Medical | 1 | 2007 | 100 | 0.070 |
Why?
| Attitude to Health | 2 | 2002 | 226 | 0.070 |
Why?
| Community Networks | 1 | 2006 | 54 | 0.070 |
Why?
| Quality of Health Care | 1 | 2007 | 219 | 0.070 |
Why?
| Education, Medical, Undergraduate | 1 | 2005 | 84 | 0.060 |
Why?
| Child Health Services | 2 | 2019 | 98 | 0.060 |
Why?
| Feasibility Studies | 2 | 2021 | 398 | 0.060 |
Why?
| Models, Econometric | 1 | 2004 | 13 | 0.060 |
Why?
| Double-Blind Method | 4 | 2003 | 743 | 0.060 |
Why?
| Risk Factors | 4 | 2008 | 3937 | 0.060 |
Why?
| Accreditation | 1 | 2004 | 73 | 0.060 |
Why?
| Cerumen | 1 | 2003 | 1 | 0.060 |
Why?
| Dioctyl Sulfosuccinic Acid | 1 | 2003 | 1 | 0.060 |
Why?
| Chlorobutanol | 1 | 2003 | 3 | 0.060 |
Why?
| Therapeutic Irrigation | 1 | 2003 | 27 | 0.060 |
Why?
| Ethanolamines | 1 | 2003 | 15 | 0.060 |
Why?
| Surface-Active Agents | 1 | 2003 | 13 | 0.060 |
Why?
| Reproducibility of Results | 1 | 2007 | 1301 | 0.060 |
Why?
| Bacterial Vaccines | 1 | 2023 | 16 | 0.060 |
Why?
| Internet | 1 | 2005 | 275 | 0.060 |
Why?
| Family Characteristics | 1 | 2023 | 58 | 0.060 |
Why?
| Research Design | 2 | 2021 | 375 | 0.050 |
Why?
| Peptides | 1 | 2003 | 276 | 0.050 |
Why?
| Poliovirus Vaccine, Inactivated | 1 | 2001 | 1 | 0.050 |
Why?
| Electronic Health Records | 1 | 2023 | 203 | 0.050 |
Why?
| Health Services Research | 1 | 2001 | 165 | 0.050 |
Why?
| Cross-Over Studies | 1 | 2021 | 250 | 0.050 |
Why?
| Registries | 1 | 2023 | 553 | 0.050 |
Why?
| Blood Pressure | 1 | 2003 | 587 | 0.050 |
Why?
| Lactose | 1 | 2000 | 10 | 0.050 |
Why?
| Statistics as Topic | 1 | 2000 | 102 | 0.050 |
Why?
| Infant Food | 1 | 2000 | 31 | 0.050 |
Why?
| Program Evaluation | 2 | 2015 | 379 | 0.050 |
Why?
| Urogenital Neoplasms | 1 | 2019 | 9 | 0.040 |
Why?
| Multicenter Studies as Topic | 1 | 2019 | 91 | 0.040 |
Why?
| Academies and Institutes | 1 | 1998 | 26 | 0.040 |
Why?
| Cluster Analysis | 1 | 2019 | 249 | 0.040 |
Why?
| Rural Health | 1 | 2019 | 102 | 0.040 |
Why?
| Influenza A virus | 1 | 1997 | 18 | 0.040 |
Why?
| Patient Compliance | 1 | 1999 | 247 | 0.040 |
Why?
| Pandemics | 1 | 2022 | 594 | 0.040 |
Why?
| Health Education | 1 | 1999 | 178 | 0.040 |
Why?
| Lead | 1 | 1997 | 32 | 0.040 |
Why?
| Educational Measurement | 2 | 1989 | 232 | 0.040 |
Why?
| Administration, Intranasal | 1 | 1996 | 29 | 0.040 |
Why?
| Motivation | 1 | 1999 | 289 | 0.040 |
Why?
| Cardiology Service, Hospital | 1 | 1996 | 22 | 0.040 |
Why?
| Pressure | 1 | 1996 | 120 | 0.030 |
Why?
| Random Allocation | 1 | 1996 | 312 | 0.030 |
Why?
| Prenatal Care | 1 | 1997 | 118 | 0.030 |
Why?
| Education, Nonprofessional | 1 | 2015 | 9 | 0.030 |
Why?
| Interprofessional Relations | 1 | 2015 | 94 | 0.030 |
Why?
| Community Health Services | 1 | 2015 | 114 | 0.030 |
Why?
| Analysis of Variance | 2 | 1997 | 634 | 0.030 |
Why?
| Parenting | 1 | 2015 | 114 | 0.030 |
Why?
| Internal Medicine | 1 | 1992 | 24 | 0.030 |
Why?
| Delivery of Health Care | 1 | 2015 | 325 | 0.030 |
Why?
| Amoxicillin-Potassium Clavulanate Combination | 1 | 1990 | 6 | 0.020 |
Why?
| Acoustic Impedance Tests | 1 | 1990 | 8 | 0.020 |
Why?
| Evaluation Studies as Topic | 1 | 1990 | 107 | 0.020 |
Why?
| Sampling Studies | 1 | 2010 | 40 | 0.020 |
Why?
| Pneumococcal Infections | 1 | 1990 | 11 | 0.020 |
Why?
| Cholesterol | 1 | 1991 | 155 | 0.020 |
Why?
| Histocompatibility Antigens Class II | 1 | 1990 | 44 | 0.020 |
Why?
| Prospective Studies | 1 | 1996 | 2606 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 1990 | 401 | 0.020 |
Why?
| Acute Disease | 1 | 1990 | 403 | 0.020 |
Why?
| Administration, Oral | 1 | 1990 | 461 | 0.020 |
Why?
| Dendritic Cells | 1 | 1990 | 142 | 0.020 |
Why?
| Epidemiologic Studies | 1 | 2008 | 30 | 0.020 |
Why?
| Ibuprofen | 1 | 2008 | 28 | 0.020 |
Why?
| Health Policy | 2 | 2001 | 171 | 0.020 |
Why?
| Analgesics | 1 | 2008 | 107 | 0.020 |
Why?
| Sepsis | 1 | 1990 | 250 | 0.020 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 142 | 0.020 |
Why?
| Myocardium | 1 | 1990 | 443 | 0.020 |
Why?
| Program Development | 1 | 2007 | 198 | 0.020 |
Why?
| Computer-Assisted Instruction | 1 | 2005 | 41 | 0.020 |
Why?
| Minority Groups | 1 | 2006 | 136 | 0.020 |
Why?
| Treatment Outcome | 1 | 1996 | 5612 | 0.020 |
Why?
| Acetaminophen | 1 | 2008 | 350 | 0.020 |
Why?
| Young Adult | 1 | 2015 | 4318 | 0.020 |
Why?
| Ear Canal | 1 | 2003 | 16 | 0.010 |
Why?
| Tympanic Membrane | 1 | 2003 | 39 | 0.010 |
Why?
| Drug Combinations | 1 | 2003 | 128 | 0.010 |
Why?
| Sodium Chloride | 1 | 2003 | 67 | 0.010 |
Why?
| Blood Pressure Determination | 1 | 2003 | 51 | 0.010 |
Why?
| Poliovirus Vaccine, Oral | 1 | 2001 | 5 | 0.010 |
Why?
| Medical Records | 1 | 2001 | 92 | 0.010 |
Why?
| Blood Urea Nitrogen | 1 | 2000 | 51 | 0.010 |
Why?
| Mass Screening | 1 | 2003 | 370 | 0.010 |
Why?
| Serum Albumin | 1 | 2000 | 62 | 0.010 |
Why?
| Anthropometry | 1 | 2000 | 96 | 0.010 |
Why?
| Creatinine | 1 | 2000 | 169 | 0.010 |
Why?
| Vaccines, Attenuated | 1 | 1997 | 8 | 0.010 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 1997 | 16 | 0.010 |
Why?
| Antibodies, Viral | 1 | 1997 | 124 | 0.010 |
Why?
| Infant, Low Birth Weight | 1 | 1997 | 76 | 0.010 |
Why?
| Maternal Exposure | 1 | 1997 | 87 | 0.010 |
Why?
| Health Care Costs | 1 | 1997 | 175 | 0.010 |
Why?
| Environmental Exposure | 1 | 1997 | 205 | 0.010 |
Why?
| Mid-Atlantic Region | 1 | 1992 | 7 | 0.010 |
Why?
| Southeastern United States | 1 | 1992 | 55 | 0.010 |
Why?
| Group Practice | 1 | 1991 | 4 | 0.010 |
Why?
| Computers | 1 | 1991 | 45 | 0.010 |
Why?
| Cues | 1 | 1991 | 55 | 0.010 |
Why?
| Major Histocompatibility Complex | 1 | 1990 | 14 | 0.010 |
Why?
| Rats, Inbred Strains | 1 | 1990 | 172 | 0.010 |
Why?
| Cost-Benefit Analysis | 1 | 1991 | 291 | 0.010 |
Why?
| Species Specificity | 1 | 1990 | 206 | 0.010 |
Why?
| Pregnancy | 1 | 1997 | 2639 | 0.010 |
Why?
| Survival Rate | 1 | 1990 | 954 | 0.000 |
Why?
| Length of Stay | 1 | 1990 | 683 | 0.000 |
Why?
| Prognosis | 1 | 1989 | 2126 | 0.000 |
Why?
| Rats | 1 | 1990 | 3419 | 0.000 |
Why?
| Aged | 1 | 1990 | 10060 | 0.000 |
Why?
| Animals | 1 | 1990 | 14409 | 0.000 |
Why?
|
|
Darden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|